DIRS.INFO The most relevant business & tech news

☆ Could decaf coffee cause cancer? Experts weigh in
▼ + stars: | 2024-04-04 | by ( Kristen Rogers | ) edition.cnn.com time to read: +8 min

Here’s what experts and the FDA say about this clause in the modern context, and what you should know about the safety of decaf coffee. “There is more information on the toxicity of methylene chloride and the levels at which it causes this toxicity,” she added. Then there is the Swiss Water Process, which decaffeinates the beans by soaking them in warm water. The Clean Label Project, an organization that tests consumer products for hidden industrial and environmental contaminants, has detected methylene chloride in several brands of coffee. What you can do nowWhether or not the FDA eventually bans methylene chloride is a decision that could take years.

Persons: Maria, Monique Richard, ”, Richard, wasn’t, ” Richard, Richard said, Dunkin Organizations: CNN, Food and Drug Administration, Occupational Safety, Health Administration, National Institutes of Health’s, Toxicology Program, Environmental Protection Agency, World Health Organization, Environmental Defense Fund, FDA, US Centers for Disease Control, EPA, Federal Food, Nutrition, maté Locations: California, Tennessee

☆ Millions of people have long Covid, including children and pregnant people, studies show
▼ + stars: | 2024-02-12 | by ( Jen Christensen | ) edition.cnn.com time to read: +6 min

CNN —Millions of people deal with Covid-19 symptoms long after their initial infections. Estimates of adults who develop long Covid range from 2.5% to 25%, although different studies have different definitions of how “long” Covid is defined. But many studies have found that vaccination lowers the risk of severe disease, which can make long Covid more likely. Long Covid symptoms in children included breathing problems like a cough, shortness of breath and chest tightness, along with fatigue. Studies haven’t fully explained what factors kids with long Covid have in common.

Persons: –, Dr, Torri Metz, ” Metz, ”, Metz, Amy Edwards, Edwards, Sanjay Gupta, haven’t Organizations: CNN, Covid, Society for, National Institutes of Health’s, University of Utah Health, UH Rainbow, Children’s Hospital, Pediatrics, Get CNN, CNN Health Locations: National Harbor , Maryland

For some people with COVID-19, antiviral pills that can be taken at home can lessen the chances of winding up in the hospital. Here’s how to get the pills in the U.S.:— Take an at-home COVID-19 test and contact your health care provider. Photos You Should See View All 45 Images— Use a test-to-treat site, where pharmacists can check if you have COVID-19, write the prescription and give you the pills all in one stop. Find a test-to-treat site at treatments.hhs.gov. Paxlovid is the most commonly prescribed antiviral pill for COVID-19.

Persons: Paxlovid, Robert Wood Johnson Organizations: National Institutes of Health’s, Pfizer, Associated Press Health, Science Department, Robert Wood Johnson Foundation, AP Locations: U.S, treatments.hhs.gov

☆ ‘Everywhere’ chemicals linked to rise in preterm births, study says
▼ + stars: | 2024-02-06 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +9 min

Now, researchers have found synthetic chemicals called phthalates used in clear food packaging and personal care products could be a culprit, according to a new study. “Studies show the largest association with preterm labor is due to a phthalate found in food packaging called Di(2-ethylhexyl) phthalate, or DEHP,” Trasande said. “In our new study, we found DEHP and three similar chemicals could be responsible for 5% to 10% of all the preterm births in 2018. “This paper focused on the relationship between exposure to individual phthalates and preterm birth. “Every day, they’re often exposed to more than one phthalate from the products they use, so the risk of preterm birth may actually be greater,” said Friedman, who was not involved in the study.

Persons: phthalates, ”, Dr, Leonardo Trasande, ” Trasande, “, that’s, Alexa Friedman, Friedman, diisononyl, toxicologist Linda Birnbaum, ” Birnbaum, birthweight, DEHP, Trasande, ” Friedman, don’t, ” CNN’s Jen Christensen Organizations: CNN, NYU Langone Health, “, Environmental, American Chemistry Council, Product Safety, FDA, Food and Drug Administration, National Institute for Environmental Health Sciences, National Toxicology, National Institutes of Health’s, Child Health, Health, Mayo Clinic, American Academy of Pediatrics, AAP Locations: United States, European

☆ Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?
▼ + stars: | 2023-11-11 | by ( Meg Tirrell | ) edition.cnn.com time to read: +9 min

To cardiologist Dr. Steven Nissen of the Cleveland Clinic, who wasn’t involved in the trial but is leading a similar one of tirzepatide, those effects are all evidence of the benefits of weight loss. Tirzepatide has shown greater levels of weight loss than semaglutide in clinical trials, leading many, including Nissen, to hope it will show even stronger cardiovascular benefits. Importantly, participants didn’t have a history of diabetes; a previous trial had shown that treating people with diabetes with a GLP-1 drug, Ozempic, reduced their cardiovascular risk. The Wegovy trial showed that 569 of 8,803 people taking the drug had a heart attack or stroke or died from heart-related causes, or 6.5%. The amount of weight loss seen in the trial, 9.4%, was less than in other studies of Wegovy, which showed average weight loss closer to 15%.

Persons: Ania Jastreboff, Wegovy, Dr, Amit Khera, National Institutes of Health’s Dr, Tiffany M, Powell, Wiley, Eli Lilly, Steven Nissen, wasn’t, ” Nissen, “, Tirzepatide, Nissen, Michael Lincoff, Lincoff, ”, Jastreboff, Sanjay Gupta, hadn’t, “ semaglutide Organizations: CNN, Nordisk’s Wegovy, American Heart Association, Yale Obesity Research Center, University of Texas Southwestern Medical Center Dallas, National Institutes of Health’s, New England, of Medicine, US Food and Drug, Cleveland Clinic, Novo Nordisk, Cleveland, CNN Health Locations: Philadelphia, Powell

☆ The US eliminated malaria in 1951. How can it keep it under control now?
▼ + stars: | 2023-08-16 | by ( Meg Tirrell | ) edition.cnn.com time to read: +10 min

“The risk is very low,” Dr. Peter McElroy, chief of the malaria branch in the US Centers for Disease Control and Prevention’s Division of Parasitic Diseases and Malaria, told CNN. In an effort to limit its impact in the southeastern US during World War II, particularly around military training bases, the US created the Office of Malaria Control in War Areas in 1942. The April 1945 edition of the Malaria Control in War Areas field bulletin. Malaria was eliminated in the United States in 1951, but modern mosquito control is mostly managed locally. Oxitec also says it’s working on applying the approach to anopheles mosquitoes for malaria control as well.

Persons: ”, Janneth Rodrigues, Rodrigues, tsuruhatensis, National Institutes of Health’s Dr, Carolina, Dr, Peter McElroy ,, haven’t, McElroy, Wade Brennan, Chandan Khanna, “, ” McElroy, Daniel Markowski, ” Markowski, They’re, Markowski, Mury, Sanjay Gupta, Aedes, Oxitec, “ We’ve Organizations: CNN, GSK, Malaria, National Institutes of Health’s, of Malaria, Vector Research, National Institute of Allergy, US Centers for Disease Control, Prevention’s, Sarasota County Mosquito Management, of Malaria Control, CDC, American Mosquito Control Association, Public Health Service, National Library of Medicine, Getty, “, CNN Health, Google Locations: Tres Cantos, Madrid, Burkina Faso, Africa, United States, Sarasota, Sarasota , Florida, Atlanta, Sarasota County , Florida, Palm Beach County , Florida, Florida, New Jersey

☆ Risky Virus Research Needs Tougher Review, Government Advisers Say
▼ + stars: | 2023-01-28 | by ( Liz Essley Whyte | ) www.wsj.com time to read: 1 min

An advisory board at the Bethesda, Md.-based National Institutes of Health unanimously backed research-oversight proposals. Virus experts advising the federal government backed proposals to bolster oversight of research that could make pathogens more dangerous or contagious. The experts, members of the National Institutes of Health’s biosecurity advisory board, voted unanimously on Friday in favor of the proposals. The NIH helps to administer the board, which gives advice to the entire U.S. government.

☆ Super Bowl-winning NFL player Ronnie Hillman dies from rare form of cancer at 31
▼ + stars: | 2022-12-22 | by ( Drew Weisholtz | ) www.nbcnews.com time to read: +2 min

Former Denver Broncos running back Ronnie Hillman, who helped the team win Super Bowl 50, died from a rare form of cancer, his family said Wednesday in a statement on Instagram. “It is with heavy hearts that we announce the passing of our beloved son, brother & father, Ronnie K Hillman Jr.,” the family said in the post. “Ronnie quietly and peacefully transitioned today in the company of his family and close friends. “As a family, we hope beyond hope, and we have faith that can move mountains,” the statement said in part. He played the first four seasons of his career with Denver, helping the team win the Super Bowl in the 2015 season.

☆ Omicron subvariants pose a new threat to people with immune deficiencies
▼ + stars: | 2022-10-23 | by ( Benjamin Ryan | ) www.nbcnews.com time to read: +7 min

Troubling recent reports reveal the emergence of new omicron subvariants that not only evade AstraZeneca’s Evusheld, the antibody drug authorized to prevent Covid infection, but also the sole antibody drug that has retained effectiveness as treatment for Covid, Eli Lilly’s bebtelovimab. Doctors have cautioned that should Laura get Covid, this could aggravate her autoimmune disease and lead to catastrophic kidney damage. Evusheld is a long-acting antibody injection given every six months that studies have suggested provides a robust buffer to the immunosuppressed. For now, immunocompromised people are anxiously watching the pandemic forecast to see if the subvariants that research indicates evade monoclonal antibodies will become predominant. “If fewer people are prescribed Evusheld,” she said, “there’s less incentive for drug companies to start developing newer therapeutics.

Search resuls for: "National Institutes of Health’s"

9 mentions found